Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular EventsMarc S. Sabatine, Evan A. Stein, Dirk Blom et al.|New England Journal of Medicine|2015Cited by 1.5k
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery DiseaseMarc P. Bonaca, Marc S. Sabatine, Patrice Nault et al.|Circulation|2017Cited by 754